Search

everythinglearnresearchcommunity

for

Search:↓

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Vaccination is crucial for public health, but anti-vaccine movements are a concern.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.